iKang shrugs off China weakness to price healthy IPO
Beijing based iKang Healthcare Group priced its $153m Nasdaq listing at the top of the range, as investors jumped at the chance to gain exposure to one of the fastest growing industries in China.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts